Cargando…
Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model
Psoriasis is a chronic inflammatory skin disease without cure. Systemic and biological therapies are the most effective treatments for patients with severe psoriasis. However, these drugs can cause serious side effects from extended use. Safe and effective topical drugs are needed to decrease psoria...
Autores principales: | Gago‐López, Nuria, Lagunas Arnal, Carmen, Perez, Juan J., Wagner, Erwin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597152/ https://www.ncbi.nlm.nih.gov/pubmed/33998705 http://dx.doi.org/10.1111/exd.14390 |
Ejemplares similares
-
Notch Signaling May Be Involved in the Abnormal Differentiation of Epidermal Keratinocytes in Psoriasis
por: Ota, Tami, et al.
Publicado: (2014) -
Inflammation, It’s Regulation and Antiphlogistic Effect of the Cyanogenic Glycoside Amygdalin
por: Figurová, Daniela, et al.
Publicado: (2021) -
Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis
por: Kitazawa, Kazuyuki, et al.
Publicado: (2021) -
Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease
por: Mellor, Liliana F, et al.
Publicado: (2022) -
PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis
por: Mercurio, Laura, et al.
Publicado: (2021)